| 2019 | The combination of the glycolysis inhibitor 2-DG and sorafenib can be effective against sorafenib-tolerant persister cancer cells | Li Wang | PMC6635829 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6635829/ | 0 |
| 2015 | 2-Deoxyglucose and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells | Minoru Tomizawa | PMC5351389 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5351389/ | 0 |
| 2021 | Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax | Blake S. Moses | — | https://ashpublications.org/bloodadvances/article/5/3/711/475059/Antileukemic-efficacy-of-a-potent-artemisinin | 0 |
| 2024 | Withaferin A, a natural thioredoxin reductase 1 (TrxR1) inhibitor, synergistically enhances the antitumor efficacy of sorafenib through ROS-mediated ER stress and DNA damage in hepatocellular carcinoma cells | Xi Chen | 38537439 | https://pubmed.ncbi.nlm.nih.gov/38537439/ | 0 |
| 2020 | Berbamine (BBM), a Natural STAT3 Inhibitor, Synergistically Enhances the Antigrowth and Proapoptotic Effects of Sorafenib on Hepatocellular Carcinoma Cells | Weijia Zhao | — | https://pubs.acs.org/doi/10.1021/acsomega.0c03527 | 0 |
| 2017 | Capsaicin exerts synergistic antitumor effect with sorafenib in hepatocellular carcinoma cells through AMPK activation | Alicia Bort | PMC5675664 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5675664/ | 0 |
| 2024 | Carvacrol potentiates immunity and sorafenib anti-cancer efficacy by targeting HIF-1α/STAT3/ FGL1 pathway: in silico and in vivo study | Eman H Yousef | PMC11978551 | https://pmc.ncbi.nlm.nih.gov/articles/PMC11978551/ | 0 |
| 2023 | Carvacrol enhances anti-tumor activity and mitigates cardiotoxicity of sorafenib in thioacetamide-induced hepatocellular carcinoma model through inhibiting TRPM7 | Eman H Yousef | 37142088 | https://pubmed.ncbi.nlm.nih.gov/37142088/ | 0 |
| 2018 | Emodin Sensitizes Hepatocellular Carcinoma Cells to the Anti-Cancer Effect of Sorafenib through Suppression of Cholesterol Metabolism | Young-Seon Kim | PMC6213641 | https://pmc.ncbi.nlm.nih.gov/articles/PMC6213641/ | 0 |
| 2015 | Fisetin, a dietary flavonoid, augments the anti-invasive and anti-metastatic potential of sorafenib in melanoma | Harish C Pal | PMC4811456 | https://pmc.ncbi.nlm.nih.gov/articles/PMC4811456/ | 0 |
| 2022 | Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways | Haofeng Lu | PMC9107598 | https://pmc.ncbi.nlm.nih.gov/articles/PMC9107598/ | 0 |
| 2026 | Synergic anticancer effects of morin hydrate and sorafenib delivered via polymeric iron oxide nanoparticles for the treatment of triple-negative breast cancer | Mingjun Li | 42599405 | https://pubmed.ncbi.nlm.nih.gov/42599405/ | 0 |